Ilika plc
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Ilika plc develops and manufactures solid-state batteries for MedTech, Industrial IoT, electric vehicles, and consumer electronics applications; its core products include the Stereax family of miniature batteries, such as the M300 model for medical implants and wireless sensors with low leakage, long cycle life, and mm-scale form factors; and the Goliath large-format batteries offering high energy density, fast charging, safety, and extended range for EVs and cordless appliances. Founded in 2004 as a spin-out from the University of Southampton and headquartered in Romsey, UK, the company operates primarily in the UK with global partnerships and targets OEMs, Tier 1 suppliers, and medical device manufacturers across Europe, North America, and Asia. Recent developments include a 2023 ten-year manufacturing license with Cirtec Medical in Massachusetts for Stereax production and commercialization support for 21 customers in orthopedics, neurostimulation, and smart lenses; a bilateral technology collaboration and heads of terms with Agratas for Goliath scale-up via the SiSTEM project adding 1.5 MWh assembly capacity; post-period fundraises of £4.2 million in 2025 and £3.5 million earlier to advance both product lines; and £1.25 million grant funding from the DRIVE35 programme commencing August 2025 with HSSMI for Goliath manufacturing.
Ilika's £500k retail offer oversubscribed
Cavendish positive on Ilika after fundraise
Cavendish positive on Ilika after fundraise
Fed bets decline after June jobs report misses forecasts
lika raises £4.56m to commercialise solid-state batteries technology
lika raises £4.56m to commercialise solid-state batteries technology
Eli Lilly weight loss drug data supports long-term obesity market position, says UBS
Goldman Sachs CEO says AI job fears ‘overblown’
Ilika advances Goliath commercialisation strategy - ICYMI
Ilika advances Goliath commercialisation strategy - ICYMI
Palo Alto Networks customers show confidence in AI security strategy at Ignite On Tour event, Jefferies says
Workday execution risk flagged by Jefferies ahead of quarterly earnings
Nvidia beats, guides higher, and Wall Street still wants more
Ilika's broadening commercial pipeline supports broker's conviction in solid-state battery play
Ilika's broadening commercial pipeline supports broker's conviction in solid-state battery play
Ilika begins generating commercial revenue from solid-state batteries
Percheron Therapeutics raises $2.2 million as HMBD-002 phase II preparations advance
FTSE 100 Live: Stocks sink as oil pushes above $117, GSK and Haleon fall on results
Palantir Technologies Q1 expectations buoyed by commercial acceleration, government contracts
Nasdaq falls back after mixed earnings, Fed holds but signals dissent